Cogent Biosciences, Inc. (COGT) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US19240Q2012
Cogent Biosciences, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Operating income | -333.36 m USD |
| EBIT | -340.56 m USD |
| Net income | -328.94 m USD |
| Diluted EPS – continuing operations | -2.16 USD |
Full history since 2015, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Cogent Biosciences, Inc.
Cogent Biosciences, Inc., a clinical-stage biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes bezuclastinib (CGT9486), a selective tyrosine kinase inhibitor in Phase 3 trial designed to target mutations within the KIT receptor tyrosine kinase, including KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found in patients with advanced gastrointestinal stromal tumors. The company also develops CGT4859, a reversible and selective fibroblast growth factor receptor 2 inhibitor in Phase 1 trial for patients with documented FGFR mutations, including advanced cholangiocarcinoma; CGT4255, a novel ErbB2 mutant program, which is focused on actionable and underserved mutations in a solid tumor systemic and CNS involved indications; and CGT6297, a Novel PI3Ka mutant-selective inhibitor. It has a licensing agreement with Plexxikon Inc. for the research, development, and commercialization of bezuclastinib. Cogent Biosciences, Inc. is headquartered in Waltham, Massachusetts.
More stocks
- Johnson Matthey PLC (JMAT.L)
- Schneider National, Inc. (SNDR)
- 3Peak Inc (688536.SS)
- Kuala Lumpur Kepong Bhd (2445.KL)
- Zhejiang Longsheng Group Co Ltd (600352.SS)
- AutoStore Holdings Ltd (AUTO.OL)
- VAIL RESORTS INC (MTN)
- E Ink Holdings (8069.TWO)
- Ameris Bancorp (ABCB)
- LondonMetric Property PLC (LMP.L)
- Blackstone Secured Lending Fund (BXSL)
- IONOS Group (IOS.DE)
Not investment advice. All data without warranty, price as of 21.10.2026. Details in the risk notice.